
  
    
      
        Introduction_NNP
        Epithelial_NNP apoptosis_NNS in_IN the_DT gastro-intestinal_JJ tract_NN is_VBZ
        normally_RB restricted_VBN to_TO superficial_JJ cells_NNS but_CC in_IN
        pathological_JJ states_NNS of_IN inflammation_NN or_CC infection_NN ,_, apoptotic_JJ
        cell_NN death_NN can_MD be_VB far_RB more_RBR expansive_JJ ._. Under_IN these_DT
        conditions_NNS apoptosis_NNS may_MD result_VB from_IN the_DT production_NN of_IN
        cytokines_NNS [_NN 1_CD ]_NN ,_, cell_NN activation_NN [_NN 2_CD 3_CD 4_CD ]_NN ,_, infective_JJ
        agents_NNS [_NN 5_CD ]_NN and_CC adverse_JJ responses_NNS to_TO pharmaceuticals_NNS [_NN 6_CD 7_CD
        ]_NN ._. Depending_VBG on_IN the_DT agonist_NN or_CC eliciting_VBG milieu_NN ,_, apoptotic_JJ
        cell_NN death_NN is_VBZ accompanied_VBN by_IN the_DT activation_NN of_IN various_JJ cell_NN
        death_NN pathways_NNS including_VBG caspases_NNS ,_, ceramide_NN ,_, altered_VBN gene_NN
        expression_NN ,_, mitochondrial_NN dysfunction_NN and_CC consumption_NN of_IN
        ATP_NNP e_SYM ._. g_SYM ._. ,_, with_IN DNA_NNP repair_NN ,_, that_DT result_NN in_IN
        histone-associated_JJ DNA_NNP fragmentation_NN [_NN 8_CD 9_CD ]_NN ._. Many_JJ of_IN
        these_DT cell_NN death_NN pathways_NNS are_VBP also_RB associated_VBN with_IN the_DT
        secondary_JJ production_NN of_IN oxidants_NNS [_NN 10_CD ]_NN which_WDT appears_VBZ to_TO
        contribute_VB to_TO the_DT magnitude_NN of_IN cell_NN death_NN ._. For_IN example_NN ,_,
        over-expression_JJ of_IN antioxidants_NNS like_IN intracellular_NN SOD_NNP
        reduces_VBZ cell_NN death_NN [_NN 11_CD ]_NN ,_, or_CC alternatively_RB ,_, depletion_NN of_IN
        antioxidant_NN reserves_NNS exacerbates_VBZ cell_NN death_NN to_TO a_DT variety_NN of_IN
        stimuli_NNS [_NN 12_CD ]_NN ._.
        Despite_IN the_DT knowledge_NN that_IN apoptosis_NNS is_VBZ increased_VBN in_IN gut_NN
        inflammation_NN ,_, either_CC from_IN idiopathic_JJ causes_NNS like_IN
        inflammatory_JJ bowel_NN disease_NN [_NN 8_CD 9_CD ]_NN or_CC associated_VBN with_IN
        infections_NNS like_IN 
        H_NNP ._. pylori_NN [_NN 13_CD ]_NN ,_, little_JJ has_VBZ been_VBN
        done_VBN to_TO examine_VB the_DT effects_NNS of_IN antioxidants_NNS on_IN epithelial_NN
        cell_NN death_NN ._. We_PRP have_VBP previously_RB demonstrated_VBN an_DT excessive_JJ
        degree_NN of_IN apoptosis_NNS in_IN patients_NNS with_IN gastritis_NNS induced_VBN by_IN 
        H_NNP ._. pylori_NN ,_, and_CC that_IN the_DT degree_NN of_IN
        apoptosis_NNS could_MD be_VB reduced_VBN by_IN dietary_JJ supplementation_NN with_IN
        vitamin_NN C_NNP ,_, irrespective_RB of_IN whether_IN the_DT infection_NN was_VBD
        cleared_VBN or_CC not_RB [_NN 13_CD ]_NN ._. This_DT observation_NN was_VBD suggestive_JJ
        that_IN dietary_JJ antioxidants_NNS could_MD limit_VB the_DT gut_NN pathology_NN by_IN
        limiting_VBG cell_NN death_NN mechanisms_NNS ._. We_PRP have_VBP also_RB demonstrated_VBN
        that_DT mesalamine_NN (_( 5_CD -_: aminosalicylic_JJ acid_NN )_) ,_, used_VBN as_IN a_DT
        frontline_NN treatment_NN for_IN inflammatory_JJ bowel_NN disease_NN ,_, could_MD
        prevent_VB apoptotic_JJ epithelial_NN cell_NN death_NN in_IN response_NN to_TO
        peroxynitrite_NN [_NN 14_CD ]_NN ._. Peroxynitrite_NNP is_VBZ a_DT potent_JJ oxidant_NN ;_:
        formed_VBN from_IN two_CD free_JJ radicals_NNS -_: nitric_JJ oxide_NN and_CC superoxide_NN
        -_: that_IN catalyzes_NNS the_DT nitration_NN of_IN tyrosine_NN residues_NNS ._. The_DT
        resultant_JJ nitrotyrosine_NN is_VBZ used_VBN as_IN a_DT marker_NN of_IN
        peroxynitrite_NN or_CC at_IN least_JJS nitration_NN reactions_NNS in_IN gastritis_NNS
        [_NN 13_CD ]_NN ,_, inflammatory_JJ bowel_NN disease_NN [_NN 15_CD 16_CD ]_NN as_RB well_RB as_IN
        general_JJ inflammation_NN [_NN 17_CD ]_NN ._. While_IN we_PRP have_VBP demonstrated_VBN
        that_IN peroxynitrite-induced_JJ apoptosis_NNS of_IN macrophages_NNS and_CC
        colon_NN epithelial_NN cells_NNS is_VBZ reduced_VBN by_IN ascorbic_JJ acid_NN [_NN 18_CD ]_NN ,_,
        it_PRP is_VBZ not_RB known_VBN if_IN other_JJ dietary_JJ antioxidants_NNS exert_VB similar_JJ
        benefits_NNS or_CC if_IN they_PRP are_VBP present_VBP in_IN epithelial_NN cells_NNS from_IN
        the_DT upper_JJ gastrointestinal_NN tract_NN ._. However_RB ,_, flavonoids_NNS and_CC
        related_VBN phenolic_JJ compounds_NNS have_VBP been_VBN described_VBN to_TO be_VB more_RBR
        effective_JJ than_IN vitamin_NN C_NNP in_IN limiting_VBG DNA_NNP damage_NN induced_VBN by_IN
        nitrating_VBG /_NN nitrosating_VBG species_NNS in_IN cell_NN free_JJ systems_NNS [_NN 19_CD ]_NN
        ._.
        Altered_NNP intracellular_NN redox_NN balance_NN with_IN depletion_NN of_IN
        antioxidant_NN reserves_NNS is_VBZ associated_VBN with_IN the_DT activation_NN of_IN
        transcription_NN factors_NNS like_IN NF-κB_NNP ,_, and_CC genes_NNS (_( TNFα_NNP ,_, IL-_NNP 1_CD β_NN )_)
        associated_VBN with_IN apoptosis_NNS ,_, proliferation_NN and_CC inflammation_NN [_NN
        3_CD 4_CD 8_CD 9_CD ]_NN ._. Indeed_RB ,_, dietary_JJ antioxidants_NNS like_IN resveratrol_NN [_NN
        20_CD ]_NN ,_, green_JJ tea_NN [_NN 21_CD ]_NN ,_, cucumin_NN [_NN 22_CD ]_NN and_CC cat_NN 's_POS claw_NN [_NN
        23_CD 24_CD ]_NN have_VBP been_VBN shown_VBN to_TO inhibit_VB gene_NN expression_NN
        associated_VBN with_IN inflammation_NN and_CC states_NNS of_IN immune_JJ
        activation_NN ._. From_IN this_DT one_PRP could_MD postulate_NN that_IN the_DT benefits_NNS
        of_IN diets_NNS rich_JJ in_IN antioxidants_NNS could_MD be_VB in_IN part_NN due_JJ to_TO a_DT
        reduction_NN in_IN signals_NNS leading_VBG to_TO apoptosis_NNS and_CC cell_NN
        activation_NN ._. This_DT possibility_NN was_VBD addressed_VBN in_IN this_DT study_NN by_IN
        examining_VBG the_DT ability_NN of_IN three_CD antioxidants_NNS ,_, vitamin_NN C_NNP and_CC
        two_CD decoctions_NNS commonly_RB used_VBN in_IN Asia_NNP and_CC South_NNP America_NNP
        (_( green_JJ tea_NN and_CC cat_NN 's_POS claw_NN )_) to_TO limit_VB epithelial_NN cell_NN
        apoptosis_NNS in_IN response_NN to_TO a_DT variety_NN of_IN oxidative_JJ stresses_NNS ._.
        The_DT latter_JJ two_CD forms_NNS of_IN antioxidants_NNS were_VBD chosen_VBN because_IN
        the_DT antioxidant_NN and_CC anti-inflammatory_JJ phytochemical_JJ
        constituents_NNS (_( polyphenols_NNS ,_, flavanols_NNS )_) are_VBP distinct_JJ from_IN
        ascorbate_NN but_CC yet_RB there_EX is_VBZ a_DT growing_VBG appreciation_NN for_IN their_PRP$
        role_NN in_IN managing_VBG disorders_NNS associated_VBN with_IN oxidative_JJ
        stress_NN ._.
      
      
        Methods_NNP
        
          Cell_NNP culture_NN
          AGS_NNP or_CC IEC-_NNP 18_CD cells_NNS were_VBD obtained_VBN from_IN the_DT American_NNP
          Type_NNP Culture_NNP Collection_NNP (_( Rockville_NNP ,_, MD_NNP )_) ._. The_DT cells_NNS were_VBD
          grown_VBN in_IN DMEM_NNP (_( high_JJ glucose_NN )_) ,_, 10_CD %_NN FCS_NNP and_CC supplemented_JJ
          with_IN 25_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 4_CD ;_: 4_CD mM_NN L-_NNP glutamine_NN ;_: 40_CD μg_NN /_NN ml_NN
          penicillin_NN ;_: 90_CD μg_NN /_NN ml_NN streptomycin_NN and_CC 1_CD ._. 2_CD g_SYM /_NN L_NNP NaHCO_NNP 
          3_CD ._. Cell_NNP cultures_NNS were_VBD maintained_VBN in_IN a_DT
          humidified_JJ 5_CD %_NN CO_NNP 
          2_CD incubator_NN at_IN 37_CD °_NN C_NNP ._. Harvested_NNP cells_NNS
          were_VBD plated_JJ in_IN 96_CD -_: well_RB microplates_NNS (_( 5_CD ×_NN 10_CD 4_CD cells_NNS /_NN well_RB )_)
          and_CC allowed_VBN to_TO grow_VB to_TO confluence_NN over_IN 24_CD h_NN before_IN use_NN ._.
          Baseline_NNP effects_NNS on_IN cell_NN proliferation_NN by_IN the_DT
          antioxidants_NNS i_NNP ._. e_SYM ._. ,_, without_IN oxidant_NN co-administration_JJ ,_, was_VBD
          followed_VBN for_IN 72_CD hours_NNS ._.
          In_IN the_DT experiments_NNS evaluating_VBG antioxidants_NNS /_NN oxidant_NN
          interactions_NNS on_IN cell_NN number_NN (_( MTT_NNP assay_NN )_) the_DT antioxidants_NNS
          were_VBD added_VBN to_TO the_DT culture_NN media_NNS 1_CD hour_NN before_IN the_DT oxidant_NN
          being_VBG evaluated_VBN ,_, with_IN incubation_NN for_IN an_DT additional_JJ 24_CD
          hours_NNS ._. At_IN the_DT conclusion_NN of_IN this_DT incubation_NN period_NN either_CC
          cell_NN number_NN was_VBD determined_VBN by_IN the_DT MTT_NNP assay_NN ._.
          The_DT cytoprotection_NN activity_NN of_IN antioxidants_NNS ,_, cat_NN 's_POS
          claw_NN ,_, green_JJ tea_NN and_CC vitamin_NN C_NNP ,_, was_VBD investigated_VBN against_IN
          the_DT toxicity_NN of_IN the_DT oxidants_NNS (_( DPPH_NNP ,_, H_NNP 
          2_CD O_NNP 
          2_CD ,_, and_CC peroxynitrite_NN )_) using_VBG acridine_NN
          orange_NN staining_VBG as_IN a_DT means_NN of_IN confirming_VBG the_DT absence_NN or_CC
          presence_NN of_IN apoptosis_NNS by_IN morphological_JJ criteria_NNS ._. Cells_NNP ,_,
          AGS_NNP or_CC IEC-_NNP 18_CD ,_, were_VBD seeded_VBN in_IN 96_CD -_: well_RB plates_NNS (_( 1_CD ._. 5_LS ×_NN 10_CD
          4_CD cells_NNS /_NN well_RB )_) and_CC treated_VBN in_IN a_DT similar_JJ manner_NN as_IN described_VBN
          above_IN for_IN the_DT DNA_NNP fragmentation_NN ELISA_NNP ._. Briefly_NNP ,_, cell_NN
          suspensions_NNS (_( 100_CD μl_NN )_) were_VBD mixed_VBN with_IN acridine_NN orange_NN (_( 5_CD
          μg_NN /_NN ml_NN )_) and_CC from_IN this_DT mixture_NN an_DT aliquot_NN of_IN 25_CD μl_NN was_VBD
          dropped_VBN on_IN to_TO a_DT microscope_NN slide_NN ._. Cells_NNP were_VBD visualized_JJ
          for_IN nuclear_JJ fragmentation_NN under_IN blue-green_JJ fluorescence_NN
          using_VBG a_DT phase-contrast_JJ inverted_JJ microscope_NN DMIRB_NNP (_( Leica_NNP
          Mikroscopie_NNP und_NN ,_, Germany_NNP )_) ._. Induction_NNP of_IN apoptosis_NNS with_IN
          the_DT oxidants_NNS was_VBD confirmed_VBN qualitatively_RB ,_, as_RB well_RB as_IN
          reduction_NN in_IN the_DT extent_NN of_IN the_DT apoptotic_JJ response_NN with_IN
          antioxidants_NNS ._. Quantification_NNP of_IN these_DT events_NNS was_VBD achieved_VBN
          with_IN the_DT Cell_NNP Death_NNP ELISA_NNP (_( DNA_NNP fragmentation_NN assay_NN )_) ._.
        
        
          DPPH_NNP radical_JJ scavenging_VBG
          The_DT DPPH_NNP radical_JJ scavenging_VBG capacity_NN as_RB previously_RB
          reported_VBD [_NN 24_CD ]_NN was_VBD modified_VBN as_IN follows_VBZ ._. The_DT aqueous_JJ
          extract_NN of_IN freeze-dried_JJ cat_NN 's_POS claw_NN (_( 
          Uncaria_NNP tomentosa_NN or_CC 
          Uncaria_NNP guianensis_NNS )_) ,_, vitamin_NN C_NNP or_CC
          green_JJ tea_NN was_VBD standardized_JJ to_TO give_VB a_DT stock_NN solution_NN (_( 25_CD
          mg_NN /_NN ml_NN )_) and_CC filtered_VBN at_IN 20_CD μm_NN using_VBG a_DT Whatman_NNP paper_NN N_NNP °_NN 4_CD ._.
          Aliquots_NNP (_( 25_CD μl_NN )_) were_VBD placed_VBN in_IN a_DT cuvette_NN and_CC an_DT
          ethanolic_JJ solution_NN of_IN DPPH_NNP (_( 100_CD μM_NN )_) was_VBD added_VBN to_TO a_DT final_JJ
          volume_NN of_IN 1_CD ml_NN ._. The_DT decrease_NN in_IN absorbance_NN at_IN 515_CD nm_NN was_VBD
          determined_VBN continuously_RB with_IN data_NNS capturing_VBG at_IN 30_CD sec_NN
          intervals_NNS with_IN a_DT spectrophotometer_NN UV-_NNP 1601_CD PC_NN (_( Shimadzu_NNP
          Corporation_NNP ,_, Japan_NNP )_) ._. The_DT degree_NN of_IN DPPH_NNP radical_JJ
          scavenging_VBG activity_NN of_IN the_DT antioxidants_NNS was_VBD calculated_VBN as_IN
          percentage_NN of_IN inhibition_NN (_( %_NN inhibition_NN )_) by_IN the_DT following_JJ
          expression_NN :_: %_NN inhibition_NN =_SYM [_NN (_( A_DT 
          control_NN -_: A_DT 
          sample_NN )_) /_NN A_DT 
          control_NN ]_NN *_NN 100_CD where_WRB A_DT control_NN is_VBZ the_DT
          absorbance_NN at_IN time_NN =_SYM 0_CD ,_, and_CC A_DT 
          sample_NN is_VBZ the_DT absorbance_NN of_IN the_DT sample_NN
          at_IN time_NN =_SYM 5_CD min_NN ._. An_DT EC_NNP 
          50_CD value_NN was_VBD determined_VBN as_IN the_DT
          concentration_NN that_IN elicited_JJ a_DT half-maximal_JJ response_NN ._.
        
        
          Hydrogen_NNP peroxide_NN scavenging_VBG
          Hydrogen_NNP peroxide_NN levels_NNS were_VBD monitored_VBN
          spectrophotometrically_RB at_IN 240_CD nm_NN in_IN a_DT manner_NN similar_JJ to_TO
          what_WP is_VBZ described_VBN above_IN for_IN DPPH_NNP ._. Reductions_NNP in_IN H_NNP 
          2_CD O_NNP 
          2_CD concentration_NN from_IN an_DT initial_JJ 50_CD μM_NN
          were_VBD calculated_VBN from_IN the_DT reduction_NN in_IN the_DT absorbance_NN
          signal_NN after_IN subtracting_VBG any_DT inherent_JJ signal_NN associated_VBN
          with_IN the_DT antioxidant_NN ._.
          Quenching_NNP of_IN peroxynitrite_NN was_VBD not_RB evaluated_VBN as_IN it_PRP can_MD
          only_RB be_VB effectively_RB studied_VBN at_IN a_DT severe_JJ alkaline_NN pH_NN ,_,
          given_VBN the_DT lability_NN of_IN peroxynitrite_NN at_IN neutral_JJ pH_NN ._.
          Peroxynitrite_NNP was_VBD synthesized_JJ as_IN previously_RB described_VBD [_NN
          14_CD ]_NN ._. Briefly_NNP ,_, solutions_NNS of_IN (_( a_DT )_) 0_CD ._. 7_CD M_NNP NaNO_NNP 
          2_CD ,_, 0_CD ._. 7_CD M_NNP H_NNP 
          2_CD O_NNP 
          2_CD and_CC (_( b_SYM )_) 0_CD ._. 6_CD M_NNP HCl_NNP ,_, were_VBD pumped_VBN using_VBG
          a_DT syringe_NN infusion_NN pump_NN (_( Harvard_NNP Apparatus_NNP ,_, South_NNP Natick_NNP ,_,
          MA_NNP )_) at_IN 25_CD ml_NN /_NN min_NN ,_, into_IN a_DT Y-_NNP junction_NN and_CC mixed_JJ in_IN a_DT 2_CD
          mm-diameter_JJ by_IN 0_CD ._. 5_CD cm_NN silica_NN tube_NN ._. The_DT mixture_NN was_VBD
          collected_VBN in_IN a_DT beaker_NN containing_VBG a_DT 1_CD ._. 5_CD M_NNP KOH_NNP solution_NN ._. To_TO
          eliminate_VB the_DT excess_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD ,_, the_DT peroxynitrite_NN solution_NN was_VBD
          filtered_VBN in_IN a_DT column_NN containing_VBG MnO_NNP 
          2_CD (_( 4_CD g_SYM )_) ._. The_DT prepared_VBN solution_NN
          contained_VBD 40_CD mM_NN peroxynitrite_NN ,_, as_IN determined_VBN by_IN
          absorbance_NN at_IN 302_CD nm_NN ._. A_DT fresh_JJ solution_NN of_IN peroxynitrite_NN
          (_( 5_CD mM_NN )_) was_VBD prepared_VBN in_IN 5_CD mM_NN KOH_NNP for_IN each_DT experiment_NN and_CC
          filtered_VBN at_IN 0_CD ._. 2_CD μm_NN ._.
        
        
          Cell_NNP death_NN photometric_JJ enzyme_NN linked_VBD immuno-sorbent_JJ
          assay_NN (_( ELISA_NNP )_)
          To_TO investigate_VB the_DT protection_NN cytotoxic_JJ effects_NNS of_IN
          oxidants_NNS (_( DPPH_NNP ,_, H_NNP 
          2_CD O_NNP 
          2_CD ,_, and_CC ONOO_NNP -_: )_) ,_, cells_NNS (_( AGS_NNP and_CC
          IEC-_NNP 18_CD )_) were_VBD seeded_VBN in_IN 96_CD -_: well_RB plates_NNS (_( 1_CD ._. 5_LS ×_NN 10_CD
          4_CD cells_NNS /_NN well_RB )_) ._. Cells_NNP were_VBD treated_VBN with_IN DPPH_NNP (_( 3_CD μM_NN )_) ,_, H_NNP 
          2_CD O_NNP 
          2_CD (_( 50_CD μM_NN )_) ,_, peroxynitrite_NN (_( 300_CD μM_NN )_)
          and_CC /_NN or_CC supplemented_JJ with_IN 10_CD μg_NN /_NN ml_NN of_IN each_DT antioxidant_NN
          (_( cat_NN 's_POS claw_NN ,_, green_JJ tea_NN ,_, ascorbic_JJ acid_NN )_) ,_, and_CC incubated_JJ for_IN
          6_CD h_NN ._. Apoptosis_NNP was_VBD quantified_VBN by_IN a_DT cellular_JJ DNA_NNP
          fragmentation_NN ELISA_NNP ._. Cell_NNP death_NN was_VBD characterized_VBN by_IN
          measuring_VBG DNA_NNP fragments_NNS released_VBN into_IN the_DT medium_NN (_( early_JJ
          necrosis_NNS and_CC late_JJ apoptosis_NNS )_) ,_, and_CC apoptosis_NNS (_( DNA_NNP
          fragments_NNS in_IN the_DT cytoplasm_NN )_) ._. The_DT assay_NN is_VBZ based_VBN on_IN the_DT
          principle_NN of_IN incubating_VBG cells_NNS with_IN the_DT non-radioactive_JJ
          thymidine_NN analogue_NN BrdU_NNP ,_, which_WDT is_VBZ added_VBN to_TO the_DT cells_NNS an_DT
          media_NNS at_IN the_DT time_NN of_IN seeding_VBG and_CC incorporated_VBN into_IN the_DT
          genomic_JJ DNA_NNP ._. BrdU-labeled_NNP DNA_NNP fragments_NNS are_VBP released_VBN from_IN
          the_DT cells_NNS into_IN the_DT cytoplasm_NN during_IN apoptosis_NNS or_CC into_IN the_DT
          cell_NN culture_NN medium_NN during_IN cell-mediated_JJ cytotoxicity_NN ._.
          The_DT DNA_NNP fragments_NNS were_VBD detected_VBN immunologically_RB by_IN the_DT
          ELISA_NNP technique_NN using_VBG an_DT anti-_NN DNA-antibody_NNP coated_JJ
          microplate_NN to_TO capture_VB the_DT DNA_NNP fragments_NNS ,_, and_CC an_DT
          anti-_NN BrdU-antibody_NNP peroxidase_NN conjugate_NN to_TO detect_VB the_DT
          BrDU_NNP contained_VBD in_IN the_DT captured_VBN DNA_NNP fragments_NNS ._. The_DT degree_NN
          of_IN apoptosis_NNS (_( cytosolic_JJ DNA_NNP fragments_NNS )_) and_CC early_JJ necrosis_NNS
          (_( DNA_NNP released_VBD into_IN the_DT medium_NN )_) was_VBD quantified_VBN following_VBG
          the_DT manufacturer_NN 's_POS recommendations_NNS (_( Roche_NNP Molecular_NNP
          Biochemicals_NNP ,_, Nutley_NNP ,_, NJ_NNP )_) ._.
        
        
          Cell_NNP membrane_NN integrity_NN (_( Necrosis_NNP )_)
          The_DT degree_NN of_IN cellular_JJ necrosis_NNS (_( cell_NN membrane_NN
          integrity_NN )_) in_IN AGS_NNP and_CC IEC-_NNP 18_CD cells_NNS was_VBD determined_VBN by_IN
          measuring_VBG the_DT level_NN of_IN lactate_NN dehydrogenase_NN (_( LDH_NNP )_)
          released_VBN into_IN culture_NN media_NNS ._. LDH_NNP release_NN was_VBD quantified_VBN
          using_VBG a_DT commercially_RB available_JJ colorimetric_JJ kit_NN (_( Sigma_NNP ,_,
          St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. Cells_NNP (_( AGS_NNP or_CC IEC-_NNP 18_CD )_) were_VBD seeded_VBN into_IN
          96_CD -_: well_RB plates_NNS (_( 1_CD ._. 5_LS ×_NN 10_CD 4_CD cells_NNS /_NN well_RB )_) and_CC allowed_VBN to_TO
          adhere_VB for_IN 24_CD hours_NNS ._. Cells_NNP were_VBD then_RB exposed_VBN to_TO oxidants_NNS
          at_IN the_DT previously_RB stated_VBN concentrations_NNS for_IN an_DT additional_JJ
          24_CD hours_NNS ._. In_IN experiments_NNS evaluating_VBG antioxidant_NN /_NN oxidant_NN
          interactions_NNS ,_, antioxidants_NNS were_VBD added_VBN to_TO the_DT culture_NN
          media_NNS 1_CD hour_NN prior_RB to_TO oxidants_NNS ._. Following_VBG a_DT 24_CD hour_NN
          incubation_NN ,_, culture_NN plates_NNS were_VBD centrifuged_JJ at_IN 250_CD ×_NN 
          g_SYM for_IN 4_CD minutes_NNS and_CC a_DT 100_CD μL_NN
          aliquot_NN transferred_VBN to_TO a_DT clean_VB 96_CD -_: well_RB plate_NN ._. The_DT amount_NN
          of_IN LDH_NNP released_VBD into_IN the_DT culture_NN media_NNS was_VBD quantified_VBN
          according_VBG to_TO the_DT protocol_NN outlined_VBN by_IN the_DT manufacturer_NN ._.
          Data_NNP were_VBD expressed_VBN as_IN the_DT percent_NN of_IN LDH_NNP released_VBD
          compared_VBN to_TO control_VB cells_NNS ._.
        
        
          Statistical_NNP analysis_NN
          Results_NNS were_VBD analyzed_VBN by_IN ANOVA_NNP with_IN post_NN hoc_FW analysis_NN ,_,
          where_WRB appropriate_JJ ,_, by_IN the_DT Dunnett_NNP 's_POS test_NN ,_, using_VBG a_DT
          commercial_JJ statistical_JJ software_NN package_NN (_( Instat_NNP ®_NN )_) ._. Data_NNP
          is_VBZ expressed_VBN as_IN the_DT mean_JJ ±_NN SEM_NNP with_IN a_DT minimum_NN of_IN three_CD
          experiments_NNS performed_VBN for_IN each_DT variable_NN ._.
        
      
      
        Results_NNS
        
          Cell_NNP proliferation_NN and_CC antioxidants_NNS
          At_IN the_DT concentrations_NNS studied_VBN ,_, addition_NN of_IN
          antioxidants_NNS to_TO either_CC AGS_NNP (_( Figure_NN 1_LS )_) or_CC IEC-_NNP 18_CD cells_NNS
          (_( Figure_NN 2_LS )_) failed_VBD to_TO affect_VB cell_NN proliferation_NN over_IN 72_CD
          hours_NNS ._.
        
        
          Cell_NNP death_NN in_IN response_NN to_TO DPPH_NNP
          In_IN response_NN to_TO the_DT addition_NN of_IN DPPH_NNP (_( 3_CD μM_NN )_) to_TO the_DT
          culture_NN media_NNS there_RB was_VBD a_DT marked_VBN induction_NN in_IN apoptosis_NNS
          as_IN determined_VBN by_IN ELISA_NNP and_CC acridine_NN orange_NN assessment_NN ._.
          This_DT response_NN was_VBD attenuated_JJ by_IN the_DT antioxidants_NNS in_IN the_DT
          following_VBG order_NN of_IN potency_NN green_JJ tea_NN >_NN cat_NN 's_POS claw_NN >_NN
          ascorbic_JJ acid_NN for_IN AGS_NNP cells_NNS (_( Figure_NN 3_LS )_) ._. Similar_JJ
          reductions_NNS in_IN apoptosis_NNS were_VBD observed_VBN in_IN IEC-_NNP 18_CD cells_NNS ,_,
          although_IN in_IN contrast_NN to_TO AGS_NNP cells_NNS differences_NNS between_IN
          antioxidants_NNS in_IN their_PRP$ cytoprotective_JJ actions_NNS were_VBD not_RB
          significant_JJ (_( Table_NNP 1_LS )_) ._.
          In_IN both_DT AGS_NNP and_CC IEC-_NNP 18_CD cells_NNS ,_, DPPH_NNP (_( 3_CD μM_NN )_) produced_VBD a_DT
          20_CD -_: 30_CD %_NN reduction_NN in_IN cell_NN viability_NN (_( Table_NNP 2_CD ,_, 3_CD and_CC 4_LS )_) ._.
          This_DT reduction_NN in_IN cell_NN viability_NN was_VBD unaffected_JJ by_IN
          antioxidants_NNS with_IN the_DT exception_NN of_IN green_JJ tea_NN ,_, which_WDT
          protected_VBD against_IN this_DT loss_NN in_IN cell_NN number_NN (_( P_NN <_NN 0_CD ._. 05_CD )_) ._.
          Using_VBG media_NNS release_NN of_IN BrdU-labeled_NNP DNA_NNP fragments_NNS as_IN an_DT
          index_NN of_IN early_JJ stage_NN necrosis_NNS ,_, it_PRP was_VBD noted_VBN that_IN DPPH_NNP (_( 3_CD
          μM_NN )_) did_VBD not_RB raise_VB rates_NNS of_IN necrosis_NNS above_IN that_DT evident_JJ in_IN
          untreated_JJ control_NN AGS_NNP cells_NNS (_( Table_NNP 4_LS )_) ._. Antioxidants_NNP did_VBD
          not_RB change_VB this_DT response_NN with_IN the_DT exception_NN of_IN cat_NN 's_POS
          claw_NN ,_, which_WDT reduced_VBD this_DT assay_NN of_IN early_JJ stage_NN necrosis_NNS (_( P_NN
          <_NN 0_CD ._. 01_CD )_) when_WRB compared_VBN to_TO either_CC control_NN (_( untreated_JJ )_)
          values_NNS or_CC the_DT cells_NNS treated_VBN with_IN DPPH_NNP ._.
          LDH_NNP release_NN into_IN the_DT media_NNS was_VBD used_VBN as_IN an_DT index_NN of_IN the_DT
          integrity_NN of_IN cell_NN membranes_NNS ,_, or_CC necrosis_NNS ,_, in_IN response_NN to_TO
          the_DT oxidant_NN burden_NN ._. Neither_DT peroxynitrite_NN or_CC H_NNP 
          2_CD O_NNP 
          2_CD at_IN the_DT concentrations_NNS chosen_VBN
          affected_VBN LDH_NNP levels_NNS in_IN either_DT AGS_NNP or_CC IEC-_NNP 18_CD cells_NNS ,_,
          indicating_VBG that_DT cell_NN death_NN by_IN necrosis_NNS was_VBD minimal_JJ ._. DPPH_NNP
          had_VBD no_DT effect_NN on_IN media_NNS LDH_NNP levels_NNS in_IN AGS_NNP cells_NNS but_CC
          significantly_RB raised_VBD levels_NNS in_IN IEC-_NNP 18_CD cells_NNS (_( Table_NNP 4_LS )_) ._.
          This_DT response_NN was_VBD attenuated_JJ by_IN cat_NN 's_POS claw_NN or_CC green_JJ tea_NN
          (_( P_NN <_NN 0_CD ._. 05_CD )_) but_CC not_RB ascorbic_JJ acid_NN (_( Table_NNP 4_LS )_) ._.
        
        
          Cell_NNP death_NN in_IN response_NN to_TO hydrogen_NN peroxide_NN
          Hydrogen_NNP peroxide_NN (_( 50_CD μM_NN )_) elicited_JJ a_DT marked_VBN increase_NN
          in_IN apoptosis_NNS in_IN AGS_NNP (_( Figure_NN 4_LS )_) and_CC IEC-_NNP 18_CD cells_NNS (_( Table_NNP
          1_LS )_) ,_, confirmed_VBN by_IN acridine_NN orange_NN morphological_JJ
          assessment_NN ._. Ascorbic_NNP acid_NN treatment_NN was_VBD less_RBR effective_JJ
          than_IN either_DT green_JJ tea_NN or_CC cat_NN 's_POS claw_NN in_IN attenuating_VBG
          hydrogen_NN peroxide-induced_JJ apoptosis_NNS in_IN AGS_NNP cells_NNS (_( P_NN <_NN
          0_CD ._. 01_CD )_) ._. In_IN a_DT manner_NN similar_JJ to_TO that_DT seen_VBN with_IN DPPH_NNP in_IN
          IEC-_NNP 18_CD cells_NNS ,_, all_DT antioxidants_NNS displayed_VBD comparable_JJ
          anti-apoptotic_JJ actions_NNS against_IN H_NNP 
          2_CD O_NNP 
          2_CD in_IN IEC-_NNP 18_CD cells_NNS (_( Table_NNP 1_LS )_) ._.
          Using_VBG the_DT release_NN of_IN BrdU-labeled_NNP DNA_NNP assay_NN for_IN early_JJ
          stage_NN necrosis_NNS ,_, it_PRP was_VBD noted_VBN that_DT hydrogen_NN peroxide_NN (_( 50_CD
          μM_NN )_) increased_VBN necrosis_NNS in_IN AGS_NNP cells_NNS by_IN approximately_RB 34_CD %_NN
          (_( Figure_NN 5_LS )_) ._. The_DT induction_NN or_CC necrosis_NNS by_IN H_NNP 
          2_CD O_NNP 
          2_CD in_IN AGS_NNP cells_NNS was_VBD prevented_VBN by_IN cat_NN 's_POS
          claw_NN ,_, green_JJ tea_NN and_CC ascorbic_JJ acid_NN (_( P_NN <_NN 0_CD ._. 01_CD )_) ._. In_IN
          contrast_NN ,_, the_DT MTT_NNP assay_NN did_VBD not_RB reveal_VB changes_NNS in_IN cell_NN
          number_NN in_IN response_NN to_TO hydrogen_NN peroxide_NN in_IN either_DT AGS_NNP or_CC
          IEC-_NNP 18_CD cells_NNS (_( Tables_NNP 2_CD and_CC 3_LS )_) ._.
        
        
          Cell_NNP death_NN in_IN response_NN to_TO Peroxynitrite_NNP
          Peroxynitrite_NNP (_( 300_CD μM_NN )_) exposure_NN reduced_VBD cell_NN number_NN
          (_( MTT_NNP assay_NN )_) that_WDT was_VBD not_RB significantly_RB altered_VBN by_IN
          antioxidant_NN therapy_NN in_IN either_DT AGS_NNP or_CC IEC-_NNP 18_CD cell_NN types_NNS
          (_( Tables_NNP 2_CD and_CC 3_LS )_) ._. Apoptosis_NNP was_VBD induced_VBN in_IN both_DT AGS_NNP and_CC
          IEC-_NNP 18_CD cells_NNS by_IN peroxynitrite_NN (_( P_NN <_NN 0_CD ._. 001_CD )_) ,_, quantified_VBN
          by_IN ELISA_NNP and_CC confirmed_VBD morphologically_RB by_IN acridine_NN
          orange_NN ._. In_IN AGS_NNP cells_NNS ,_, ascorbic_JJ acid_NN caused_VBD a_DT reduction_NN in_IN
          the_DT apoptotic_JJ response_NN to_TO peroxynitrite_NN (_( P_NN <_NN 0_CD ._. 01_CD )_) ._.
          However_RB ,_, both_DT cat_NN 's_POS claw_NN or_CC green_JJ tea_NN treatment_NN were_VBD more_RBR
          effective_JJ than_IN ascorbate_NN in_IN reducing_VBG the_DT apoptotic_JJ
          response_NN to_TO peroxynitrite_NN (_( P_NN <_NN 0_CD ._. 05_CD ,_, Figure_NN 6_CD )_) ._. Values_NNP
          for_IN apoptosis_NNS for_IN green_JJ tea_NN or_CC cat_NN 's_POS claw_NN ,_, but_CC not_RB
          ascorbate_NN ,_, were_VBD lowered_VBN to_TO a_DT level_NN that_WDT was_VBD
          indistinguishable_JJ from_IN control_NN ,_, untreated_JJ cells_NNS ._. Using_VBG
          the_DT media_NNS release_NN of_IN BrdU-labeled_NNP DNA_NNP as_IN an_DT index_NN of_IN
          early_JJ necrotic_JJ cell_NN death_NN ,_, it_PRP was_VBD observed_VBN that_DT
          peroxynitrite_NN treatment_NN induced_VBD necrosis_NNS in_IN AGS_NNP cells_NNS (_( P_NN
          <_NN 0_CD ._. 001_CD )_) ._. This_DT effect_NN was_VBD reduced_VBN by_IN either_DT cat_NN 's_POS claw_NN
          (_( P_NN <_NN 0_CD ._. 001_CD )_) or_CC green_JJ tea_NN (_( P_NN <_NN 0_CD ._. 01_CD )_) but_CC not_RB
          ascorbic_JJ acid_NN (_( Figure_NN 7_CD )_) ._. In_IN contrast_NN ,_, in_IN IEC-_NNP 18_CD cells_NNS
          all_DT three_CD antioxidants_NNS produced_VBD similar_JJ degrees_NNS of_IN
          cytoprotection_NN ,_, limiting_VBG peroxynitrite-induced_JJ apoptosis_NNS
          (_( Table_NNP 1_LS )_) ._.
        
        
          DPPH_NNP radical_JJ and_CC Hydrogen_NNP Peroxide_NNP quenching_VBG
          The_DT DPPH_NNP radical_JJ was_VBD quenched_JJ by_IN the_DT antioxidants_NNS as_IN
          indicated_VBN by_IN an_DT acceleration_NN of_IN the_DT decay_NN of_IN the_DT
          absorbance_NN signal_NN (_( 515_CD nm_NN )_) ._. Ascorbic_NNP acid_NN was_VBD
          significantly_RB more_RBR potent_JJ than_IN green_JJ tea_NN or_CC cat_NN 's_POS claw_NN (_( P_NN
          <_NN 0_CD ._. 05_CD )_) ,_, with_IN green_JJ tea_NN being_VBG more_RBR effective_JJ than_IN
          cat_NN 's_POS claw_NN (_( P_NN <_NN 0_CD ._. 05_CD )_) ._. The_DT EC_NNP 
          50_CD activities_NNS for_IN these_DT antioxidants_NNS
          against_IN DPPH_NNP are_VBP summarized_VBD in_IN Table_NNP 5_CD ._. This_DT rank_NN order_NN
          of_IN potency_NN contrasts_VBZ the_DT rank_NN order_NN of_IN potency_NN in_IN
          protecting_VBG epithelial_NN cells_NNS form_VBP DPPH-induced_NNP
          apoptosis_NNS ._.
          The_DT hydrogen_NN peroxide_NN signal_NN ,_, determined_VBN by_IN
          spectroscopy_NN at_IN 240_CD nm_NN ,_, was_VBD quenched_JJ by_IN ascorbic_JJ acid_NN but_CC
          not_RB by_IN the_DT decoctions_NNS ,_, green_JJ tea_NN or_CC cat_NN 's_POS claw_NN ._. Results_NNS
          are_VBP summarized_VBD in_IN Table_NNP 5_CD ._.
        
      
      
        Discussion_NNP
        From_IN this_DT study_NN it_PRP is_VBZ clear_JJ that_IN concentrations_NNS of_IN
        oxidants_NNS that_WDT elicit_NN minimal_JJ to_TO minor_JJ degrees_NNS of_IN epithelial_NN
        cell_NN necrosis_NNS can_MD promote_VB significant_JJ apoptotic_JJ cell_NN death_NN ._.
        This_DT result_NN is_VBZ not_RB specific_JJ to_TO a_DT particular_JJ oxidant_NN ,_, as_IN a_DT
        comparable_JJ response_NN was_VBD observed_VBN with_IN the_DT three_CD distinct_JJ
        oxidants_NNS -_: peroxynitrite_NN ,_, hydrogen_NN peroxide_NN ,_, and_CC the_DT free_JJ
        radical_JJ DPPH_NNP ._. In_IN each_DT case_NN ,_, these_DT oxidants_NNS caused_VBD
        significant_JJ apoptosis_NNS and_CC cell_NN death_NN which_WDT was_VBD dramatically_RB
        reduced_VBN by_IN the_DT addition_NN of_IN dietary_JJ antioxidants_NNS ._. With_IN the_DT
        exception_NN of_IN vitamin_NN C_NNP ,_, the_DT potency_NN of_IN these_DT antioxidants_NNS
        as_IN cytoprotective_JJ (_( anti-apoptotic_JJ )_) agents_NNS ,_, appears_VBZ to_TO
        exceed_VB their_PRP$ inherent_JJ ability_NN to_TO quench_NN the_DT specific_JJ
        oxidant_NN stimulus_NN ._. In_IN other_JJ words_NNS ,_, at_IN concentrations_NNS of_IN
        green_JJ tea_NN or_CC cat_NN 's_POS claw_NN that_WDT had_VBD minimal_JJ quenching_VBG effects_NNS
        on_IN the_DT oxidant_NN signal_NN itself_PRP ,_, a_DT significant_JJ benefit_NN to_TO
        cellular_JJ systems_NNS was_VBD seen_VBN ._. This_DT may_MD reflect_VB the_DT combined_VBN
        contributions_NNS of_IN intracellular_NN antioxidants_NNS with_IN the_DT
        exogenous_JJ antioxidant_NN ._. However_RB ,_, if_IN that_DT were_VBD the_DT sole_JJ
        explanation_NN ,_, the_DT rank_NN order_NN of_IN potency_NN would_MD not_RB change_VB
        when_WRB switching_VBG from_IN cell_NN free_JJ to_TO cellular_JJ systems_NNS ._.
        Ascorbate_NNP would_MD remain_VB more_RBR effective_JJ ,_, rather_RB than_IN being_VBG
        the_DT weakest_JJS of_IN the_DT antioxidants_NNS studied_VBN to_TO limit_VB apoptosis_NNS
        (_( in_IN AGS_NNP cells_NNS )_) ._. It_PRP appears_VBZ that_IN other_JJ factors_NNS influence_VBP the_DT
        anti-apoptotic_JJ activity_NN of_IN antioxidants_NNS ._.
        We_PRP chose_VBD to_TO evaluate_VB cat_NN 's_POS claw_NN and_CC green_JJ tea_NN for_IN
        several_JJ reasons_NNS ._. Beyond_IN being_VBG extracts_NNS and_CC hence_RB they_PRP are_VBP
        made_VBN up_RP of_IN a_DT collection_NN of_IN phytochemicals_NNS ,_, in_IN contrast_NN to_TO
        vitamin_NN C_NNP ,_, these_DT "_'' teas_NNS "_'' are_VBP used_VBN for_IN health_NN maintenance_NN in_IN
        various_JJ cultures_NNS ._. Recently_RB ,_, both_DT green_JJ tea_NN and_CC cat_NN 's_POS claw_NN
        have_VBP been_VBN reported_VBN to_TO reduce_VB the_DT expression_NN of_IN inflammatory_JJ
        genes_NNS ;_: responses_NNS that_WDT are_VBP linked_VBN to_TO apoptosis_NNS and_CC
        proliferation_NN [_NN 23_CD 24_CD 25_CD 26_CD 27_CD ]_NN ._. Indeed_RB ,_, cat_NN 's_POS claw_NN has_VBZ
        been_VBN described_VBN as_IN a_DT potent_JJ inhibitor_NN of_IN the_DT transcription_NN
        factor_NN NF-κB_NNP activation_NN ,_, preventing_VBG the_DT expression_NN of_IN TNFα_NNP
        and_CC inducible_JJ nitric_JJ oxide_NN synthase_NN [_NN 23_CD 24_CD ]_NN ._. These_DT
        immune_JJ /_NN inflammatory_JJ products_NNS are_VBP associated_VBN with_IN gastritis_NNS
        and_CC epithelial_NN cell_NN death_NN [_NN 5_CD 6_CD 7_CD 13_CD ]_NN and_CC hence_RB cat_NN 's_POS claw_NN
        may_MD have_VB utility_NN in_IN limiting_VBG gut_NN inflammation_NN [_NN 23_CD ]_NN ._.
        Indeed_RB ,_, this_DT matches_VBZ its_PRP$ ethnomedical_JJ use_NN in_IN South_NNP America_NNP
        where_WRB it_PRP is_VBZ used_VBN to_TO treat_VB gastritis_NNS and_CC other_JJ forms_NNS of_IN
        chronic_JJ inflammation_NN like_IN arthritis_NN [_NN 28_CD ]_NN ._. Green_NNP tea_NN ,_, and_CC
        its_PRP$ constituent_NN polyphenols_NNS ,_, has_VBZ been_VBN associated_VBN with_IN
        reduced_VBN expression_NN of_IN inflammatory_JJ genes_NNS and_CC signal_NN
        transduction_NN processes_VBZ leading_VBG to_TO cell_NN death_NN [_NN 21_CD 25_CD 26_CD 27_CD
        ]_NN ._.
        We_PRP focused_VBD on_IN epithelial_NN cells_NNS of_IN the_DT upper_JJ
        gastrointestinal_NN tract_NN because_IN the_DT sites_NNS of_IN highest_JJS
        epithelial_NN exposure_NN to_TO these_DT dietary_JJ antioxidants_NNS would_MD be_VB
        the_DT stomach_NN and_CC small_JJ intestine_NN following_VBG ingestion_NN ._. While_IN
        it_PRP is_VBZ likely_JJ that_IN these_DT antioxidants_NNS are_VBP absorbed_VBN and_CC exert_VB
        actions_NNS from_IN the_DT vascular_NN space_NN systemically_RB (_( hence_RB
        applications_NNS in_IN arthritis_NN )_) ,_, knowledge_NN of_IN their_PRP$
        pharmacokinetics_NNS is_VBZ limited_VBN ._. Given_VBN that_IN gastritis_NNS ,_, whether_IN
        it_PRP is_VBZ induced_VBN by_IN infection_NN with_IN 
        H_NNP ._. pylori_NN or_CC toxicity_NN responses_NNS to_TO
        NSAIDs_NNP ,_, is_VBZ associated_VBN with_IN NF-κB_NNP activation_NN ,_, TNFα_NNP
        expression_NN and_CC apoptosis_NNS in_IN epithelial_NN cells_NNS [_NN 5_CD 6_CD 7_CD ]_NN ,_,
        strategies_NNS to_TO limit_VB these_DT responses_NNS may_MD have_VB significant_JJ
        therapeutic_JJ potential_NN ._. This_DT is_VBZ particularly_RB true_JJ if_IN the_DT
        therapeutic_JJ modalities_NNS are_VBP available_JJ to_TO a_DT wide_JJ section_NN of_IN
        the_DT population_NN for_IN little_JJ expense_NN ._. However_RB ,_, the_DT doses_NNS of_IN
        antioxidants_NNS used_VBN in_IN this_DT study_NN are_VBP above_IN that_DT noted_VBD with_IN
        diet_NN or_CC simple_JJ tea_NN consumption_NN and_CC are_VBP more_RBR reflective_JJ of_IN
        therapeutic_JJ intervention_NN based_VBN on_IN dietary_JJ
        supplementation_NN ._.
        Gastritis_NNP associated_VBN with_IN persistent_JJ 
        H_NNP ._. pylori_NN infection_NN is_VBZ associated_VBN
        with_IN an_DT increased_VBN incidence_NN of_IN gastric_JJ cancer_NN ._. Whether_IN
        dietary_JJ antioxidant_NN supplementation_NN retards_NNS this_DT expression_NN
        has_VBZ been_VBN an_DT appealing_VBG hypothesis_NNS ._. Several_JJ lines_NNS of_IN evidence_NN
        support_NN this_DT contention_NN ._. Correa_NNP et_CC al_NN [_NN 29_CD ]_NN have_VBP clearly_RB
        shown_VBN in_IN a_DT large_JJ trial_NN conducted_VBN over_IN six_CD years_NNS that_IN
        dietary_JJ antioxidant_NN supplementation_NN alone_RB (_( vitamin_NN C_NNP or_CC
        beta-carotene_JJ )_) ,_, without_IN antimicrobial_NN therapy_NN ,_, can_MD limit_VB
        the_DT progress_NN of_IN gastric_JJ cancer_NN and_CC actually_RB may_MD promote_VB
        regression_NN of_IN precancerous_JJ states_NNS ._. Additionally_RB ,_, it_PRP appears_VBZ
        that_IN the_DT population_NN sub-groups_JJ at_IN greatest_JJS risk_NN for_IN gastric_JJ
        cancer_NN have_VBP a_DT limited_JJ ability_NN to_TO secrete_NN ascorbic_JJ acid_NN from_IN
        the_DT plasma_NN through_IN the_DT mucosal_NN and_CC into_IN the_DT gastric_JJ lumen_NN [_NN
        30_CD ]_NN ._. In_IN a_DT related_VBN study_NN ,_, supplementation_NN with_IN vitamin_NN C_NNP
        reduces_VBZ the_DT degree_NN of_IN apoptosis_NNS and_CC nitrotyrosine_NN
        immunohistochemistry_NN [_NN 13_CD ]_NN ,_, a_DT marker_NN of_IN peroxynitrite_NN
        formation_NN [_NN 15_CD ]_NN ._. NF-κB_NNP is_VBZ activated_VBN in_IN gastric_JJ epithelia_NN
        with_IN 
        H_NNP ._. pylori_NN infection_NN ,_, and_CC clearance_NN of_IN
        this_DT infection_NN reduced_VBD NF-κB_NNP levels_NNS as_RB well_RB as_IN expression_NN
        of_IN inducible_JJ nitric_JJ oxide_NN [_NN 5_CD 13_CD ]_NN ,_, thereby_RB reducing_VBG the_DT
        mucosal_NN burden_NN of_IN nitric_JJ oxide_NN and_CC possibly_RB peroxynitrite_NN ._.
        While_IN clearance_NN of_IN the_DT infection_NN is_VBZ curative_JJ ,_, much_JJ of_IN the_DT
        world_NN 's_POS population_NN cannot_NN afford_VBP the_DT therapy_NN ,_, and_CC further_JJ
        clearance_NN of_IN the_DT infection_NN with_IN antimicrobial_NN therapy_NN is_VBZ
        not_RB guaranteed_VBN ._. Thus_RB ,_, treating_VBG the_DT host_NN response_NN to_TO the_DT
        infection_NN with_IN common_JJ ,_, readily_RB available_JJ antioxidants_NNS may_MD
        afford_VB some_DT degree_NN of_IN protection_NN ._. In_IN contrast_NN ,_, a_DT recent_JJ
        study_NN in_IN Japan_NNP indicated_VBD that_IN the_DT consumption_NN of_IN green_JJ tea_NN
        was_VBD not_RB associated_VBN with_IN either_DT a_DT reduction_NN or_CC an_DT increase_NN
        in_IN gastric_JJ cancer_NN rates_NNS [_NN 31_CD ]_NN ._. This_DT raises_VBZ concern_NN as_IN to_TO
        the_DT ability_NN of_IN polyphenols_NNS derived_VBN from_IN green_JJ tea_NN to_TO afford_VB
        protection_NN from_IN mutagenic_JJ substances_NNS or_CC limit_VB the_DT
        progression_NN of_IN established_VBN cancer_NN ._. However_RB ,_, the_DT discrepancy_NN
        is_VBZ more_RBR likely_JJ a_DT reflection_NN that_IN higher_JJR doses_NNS of_IN
        polyphenols_NNS are_VBP required_VBN to_TO achieve_VB benefit_NN than_IN that_DT which_WDT
        is_VBZ achieved_VBN with_IN simple_JJ ingestion_NN of_IN tea_NN ._. This_DT is_VBZ evident_JJ
        when_WRB one_CD evaluates_VBZ the_DT concentrations_NNS required_VBN to_TO achieve_VB
        anticancer_NN ,_, cytoprotective_JJ actions_NNS in_IN vitro_NN [_NN 19_CD 21_CD 25_CD 26_CD
        27_CD ]_NN ._. More_RBR recently_RB in_IN the_DT 
        Apc_NNP minmouse_NN model_NN of_IN familial_NN
        adenomatous_JJ polyposis_NNS ,_, a_DT condition_NN with_IN a_DT massive_JJ induction_NN
        of_IN polyps_NNS in_IN the_DT gastrointestinal_NN tract_NN ,_, green_JJ tea_NN extracts_NNS
        reduced_VBD polyp_NN load_NN and_CC potentiated_JJ the_DT effects_NNS of_IN sulindac_NN ,_,
        a_DT cyclo-oxygenase_JJ inhibitor_NN used_VBN to_TO treat_VB gastrointestinal_NN
        cancer_NN [_NN 32_CD ]_NN ._. This_DT further_JJ affirms_NNS the_DT potential_NN of_IN this_DT
        strategy_NN in_IN managing_VBG disorders_NNS characterized_VBN by_IN epithelial_NN
        cell_NN death_NN and_CC transformation_NN ._.
        The_DT gastric_JJ mucosal_NN responses_NNS to_TO non-steroidal_JJ
        anti-inflammatory_JJ drugs_NNS also_RB involve_VBP the_DT activation_NN of_IN
        NF-κB_NNP ,_, generation_NN of_IN cytotoxic_JJ cytokines_NNS like_IN TNFα_NNP and_CC
        epithelial_NN apoptosis_NNS [_NN 6_CD 7_CD ]_NN ._. Administration_NNP of_IN low_JJ
        concentrations_NNS of_IN nitric_JJ oxide_NN by_IN an_DT ester_NN linkage_NN reduces_VBZ
        this_DT effect_NN ,_, suggesting_VBG that_IN nitric_JJ oxide_NN was_VBD offering_VBG
        benefit_NN by_IN quenching_VBG other_JJ radicals_NNS involved_VBN in_IN cell_NN
        activation_NN ._. Under_IN these_DT circumstances_NNS ,_, could_MD
        co-administration_JJ of_IN dietary_JJ antioxidants_NNS also_RB limit_VBP the_DT
        toxicity_NN of_IN the_DT pharmaceutical_NN ?_. If_IN so_RB ,_, this_DT approach_NN could_MD
        offer_VB significant_JJ cost_NN savings_NNS over_IN the_DT use_NN of_IN newer_JJR
        cyclo-oxygenase_JJ 2_CD (_( COX_NNP 2_LS )_) inhibitors_NNS ._. In_IN a_DT recent_JJ paper_NN by_IN
        Laine_NNP [_NN 33_CD ]_NN ,_, it_PRP was_VBD calculated_VBN that_IN although_IN COX_NNP 2_CD
        inhibitors_NNS reduced_VBD the_DT incidence_NN of_IN gastrointestinal_NN damage_NN
        when_WRB compared_VBN to_TO non-selective_JJ COX_NNP inhibitors_NNS ,_, these_DT
        benefits_NNS were_VBD achieved_VBN at_IN a_DT significant_JJ increase_NN in_IN health_NN
        care_NN costs_NNS (_( approximately_RB $_$ 560_CD per_IN patient_NN per_IN year_NN )_) ._. In_IN
        contrast_NN ,_, we_PRP have_VBP reported_VBN that_DT cat_NN 's_POS claw_NN prevents_VBZ the_DT
        significant_JJ enteropathy_NN associated_VBN with_IN sustained_VBN use_NN of_IN
        indomethacin_NN ,_, a_DT non-selective_JJ COX_NNP inhibitor_NN [_NN 23_CD ]_NN ,_, and_CC
        this_DT combination_NN could_MD alleviate_VB the_DT gastrointestinal_NN
        damage_NN without_IN the_DT high_JJ costs_NNS of_IN COX_NNP 2_CD inhibitors_NNS ._.
        In_IN the_DT present_JJ study_NN ,_, oxidant_NN stress_NN was_VBD induced_VBN by_IN
        signals_NNS that_WDT are_VBP largely_RB hydrophilic_JJ ._. In_IN other_JJ words_NNS
        apoptosis_NNS was_VBD not_RB provoked_VBN with_IN lipid_NN peroxides_NNS ._. As_IN the_DT
        chosen_VBN antioxidants_NNS were_VBD hydrophilic_JJ ,_, a_DT significant_JJ
        interaction_NN was_VBD anticipated_VBN ._. However_RB ,_, these_DT antioxidants_NNS
        may_MD be_VB less_RBR effective_JJ against_IN a_DT lipid_NN peroxide_NN generating_NN
        system_NN ,_, and_CC under_IN those_DT conditions_NNS an_DT antioxidant_NN like_IN
        vitamin_NN E_NNP may_MD be_VB more_RBR effective_JJ ._. However_RB ,_, lipid_NN
        hydroperoxide-induced_JJ apoptosis_NNS is_VBZ accompanied_VBN by_IN an_DT
        alteration_NN in_IN the_DT intracellular_NN redox_NN balance_NN leading_VBG to_TO a_DT
        depletion_NN of_IN intracellular_NN thiols_NNS and_CC subsequent_JJ activation_NN
        of_IN caspases_NNS and_CC PARP_NNP cleavage_NN [_NN 33_CD ]_NN ,_, responses_NNS that_WDT would_MD
        be_VB attenuated_JJ by_IN hydrophilic_JJ antioxidants_NNS ._.
        Peroxynitrite_NNP is_VBZ a_DT potent_JJ oxidant_NN that_WDT can_MD induce_VB lipid_NN
        peroxidation_NN and_CC as_IN such_JJ may_MD provide_VB important_JJ insight_NN ._.
        However_RB ,_, endogenous_JJ production_NN of_IN peroxynitrite_NN remains_VBZ
        controversial_JJ ._. Nitration_NNP of_IN tyrosine_NN residues_NNS is_VBZ used_VBN as_IN an_DT
        index_NN of_IN peroxynitrite_NN formation_NN but_CC it_PRP is_VBZ not_RB specific_JJ [_NN
        13_CD ]_NN ._. However_RB ,_, the_DT purpose_NN of_IN using_VBG peroxynitrite_NN in_IN this_DT
        study_NN was_VBD to_TO address_VB the_DT effects_NNS of_IN a_DT potent_JJ oxidant_NN and_CC
        not_RB to_TO evaluate_VB the_DT role_NN of_IN peroxynitrite_NN in_IN pathological_JJ
        states_NNS ._. Indeed_RB some_DT oxidants_NNS may_MD be_VB environmental_JJ and_CC not_RB
        produced_VBN endogenously_RB but_CC yet_RB antioxidant_NN supplementation_NN
        may_MD provide_VB therapeutic_JJ utility_NN ._.
        In_IN the_DT present_JJ study_NN ,_, AGS_NNP cells_NNS (_( human_JJ gastric_JJ
        epithelial_NN cells_NNS )_) were_VBD used_VBN ._. AGS_NNP are_VBP a_DT transformed_VBN cell_NN
        line_NN ,_, consequently_RB ,_, one_PRP could_MD argue_VB that_IN dietary_JJ
        antioxidants_NNS could_MD prevent_VB the_DT elimination_NN of_IN these_DT
        transformed_VBN cells_NNS by_IN the_DT mucosal_NN immune_JJ response_NN ._. Indeed_RB
        that_WDT is_VBZ a_DT concern_NN that_WDT has_VBZ been_VBN raised_VBN following_VBG the_DT
        failure_NN of_IN prospective_JJ antioxidant_NN trials_NNS in_IN smokers_NNS to_TO
        limit_VB the_DT incidence_NN /_NN progression_NN of_IN lung_NN cancer_NN [_NN 35_CD ]_NN and_CC
        the_DT recent_JJ epidemiological_JJ analysis_NN of_IN gastric_JJ cancer_NN
        incidence_NN and_CC green_JJ tea_NN consumption_NN [_NN 32_CD ]_NN ._. However_RB ,_, other_JJ
        evidence_NN has_VBZ indicated_VBN that_IN the_DT antioxidants_NNS ,_, vitamin_NN E_NNP or_CC
        N-_NNP acetylcysteine_NN ,_, enhanced_VBD the_DT ability_NN of_IN the_DT
        chemotherapeutic_JJ agent_NN 5_CD -_: fluorouracil_NN to_TO induce_VB apoptosis_NNS
        in_IN colon_NN cancer_NN cells_NNS [_NN 36_CD ]_NN ._. These_DT in_IN vitro_NN observations_NNS
        are_VBP supported_VBN by_IN the_DT 
        Apc_NNP minanimal_NN model_NN [_NN 32_CD ]_NN and_CC
        sustained_VBN clinical_JJ trial_NN in_IN patients_NNS with_IN 
        H_NNP ._. pylori_NN gastritis_NNS [_NN 30_CD ]_NN suggesting_VBG
        that_IN dietary_JJ antioxidants_NNS do_VBP not_RB exacerbate_VB precancerous_JJ
        states_NNS but_CC may_MD indeed_RB promote_VB regression_NN ._. In_IN addition_NN ,_,
        cells_NNS of_IN a_DT lymphoid_NN origin_NN where_WRB NF-κB_NNP is_VBZ constitutively_RB
        activated_VBN ,_, inhibition_NN of_IN NF-κB_NNP confers_VBZ complete_JJ protection_NN
        to_TO hydrogen_NN peroxide_NN and_CC pervanadate_NN ,_, but_CC rendered_VBD HeLa_NNP
        cells_NNS more_RBR susceptible_JJ to_TO apoptosis_NNS induced_VBN by_IN TNFα_NNP [_NN 37_CD ]_NN
        ._.
      
      
        Conclusion_NNP
        Dietary_NNP antioxidants_NNS confer_VBP significant_JJ protection_NN to_TO
        gut_VB epithelial_NN cells_NNS from_IN pro-apoptotic_JJ oxidant_NN stress_NN ._. The_DT
        phytochemical_JJ mixtures_NNS found_VBD in_IN the_DT teas_NNS ,_, cat_NN 's_POS claw_NN and_CC
        green_JJ tea_NN ,_, appear_VB to_TO be_VB more_RBR effective_JJ than_IN vitamin_NN C_NNP in_IN
        some_DT cell_NN lines_NNS and_CC at_IN concentrations_NNS that_WDT suggest_VBP that_IN
        they_PRP may_MD be_VB acting_VBG at_IN levels_NNS distinct_JJ from_IN the_DT mere_JJ
        scavenging_VBG of_IN the_DT oxidant_NN signal_NN ._. Diet_NNP supplementation_NN with_IN
        these_DT or_CC related_VBN antioxidants_NNS may_MD prove_VB valuable_JJ in_IN
        limiting_VBG the_DT pathophysiology_NN of_IN numerous_JJ disorders_NNS
        associated_VBN with_IN gut_NN inflammation_NN ._.
      
      
        Competing_VBG interests_NNS
        There_EX are_VBP no_DT competing_VBG interests_NNS for_IN BK_NNP Reuter_NNP or_CC F_NN ._.
        Angeles_NNP ._. Both_DT MJS_NNP Miller_NNP and_CC M_NNP Sandoval_NNP have_VBP financial_JJ
        interests_NNS in_IN Rainforest_NNP Phytoceuticals_NNP ,_, LLC_NNP who_WP supplied_VBD
        the_DT cat_NN 's_POS claw_NN used_VBD in_IN this_DT study_NN ._.
      
    
  
